← Company directoryNASDAQ · SEC EDGAR
GT Biopharma, Inc.
GTBPA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
GT Biopharma 1-for-25 reverse stock split
GT Biopharma common stock will undergo a 1-for-25 reverse split effective 8 September. The GTBP ticker will remain unchanged and the new CUSIP will be 36254L407.
Nasdaq ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
GSRVRGSR V Acquisition Corp. - RightsNASDAQ · SEC→GSRVUGSR V Acquisition Corp. - UnitsNASDAQ · SEC→GSUNGolden Sun Technology Group Limited - Class A Ordinary SharesNASDAQ · SEC→GTThe Goodyear Tire & Rubber CompanyNASDAQ · SEC→GTECGreenland Technologies Holding Corporation - Class A Ordinary SharesNASDAQ · SEC→GTENGores Holdings X, Inc. - Class A ordinary sharesNASDAQ · SEC→GTENUGores Holdings X, Inc. - UnitsNASDAQ · SEC→GTENWGores Holdings X, Inc. - WarrantsNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.